Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Helminthiasis | 2 | 2018 | 78 | 1.33 | Why? |
| Schistosoma | 1 | 2018 | 6 | 0.78 | Why? |
| Helminths | 1 | 2018 | 60 | 0.71 | Why? |
| Soil | 1 | 2018 | 137 | 0.70 | Why? |
| Schistosomiasis | 1 | 2018 | 59 | 0.69 | Why? |
| Blood Specimen Collection | 1 | 2021 | 387 | 0.65 | Why? |
| Community Participation | 1 | 2021 | 605 | 0.54 | Why? |
| Feces | 2 | 2018 | 4235 | 0.33 | Why? |
| Molecular Diagnostic Techniques | 2 | 2021 | 4239 | 0.29 | Why? |
| Leishmaniasis, Visceral | 2 | 2018 | 85 | 0.29 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.22 | Why? |
| Necatoriasis | 1 | 2018 | 1 | 0.20 | Why? |
| Necator americanus | 1 | 2018 | 4 | 0.20 | Why? |
| Transition Temperature | 1 | 2018 | 11 | 0.19 | Why? |
| Granuloma, Pyogenic | 1 | 2018 | 11 | 0.19 | Why? |
| Ascaris lumbricoides | 1 | 2018 | 11 | 0.19 | Why? |
| Conjunctival Neoplasms | 1 | 2018 | 17 | 0.19 | Why? |
| Ascariasis | 1 | 2018 | 21 | 0.19 | Why? |
| Phlebotomus | 1 | 2018 | 11 | 0.19 | Why? |
| Orbital Neoplasms | 1 | 2018 | 27 | 0.19 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.19 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2019 | 48 | 0.19 | Why? |
| Choriocarcinoma, Non-gestational | 1 | 2017 | 1 | 0.19 | Why? |
| Choriocarcinoma | 1 | 2017 | 8 | 0.18 | Why? |
| Tropical Medicine | 1 | 2021 | 237 | 0.18 | Why? |
| Eye Neoplasms | 1 | 2018 | 71 | 0.18 | Why? |
| Methamphetamine | 1 | 2019 | 82 | 0.18 | Why? |
| Strongyloides stercoralis | 1 | 2018 | 70 | 0.17 | Why? |
| Dried Blood Spot Testing | 1 | 2021 | 383 | 0.17 | Why? |
| Strongyloidiasis | 1 | 2018 | 80 | 0.17 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 179 | 0.17 | Why? |
| Uterine Neoplasms | 1 | 2017 | 70 | 0.16 | Why? |
| Insecticides | 1 | 2018 | 178 | 0.16 | Why? |
| Ghana | 1 | 2018 | 763 | 0.14 | Why? |
| Leishmania infantum | 1 | 2013 | 29 | 0.13 | Why? |
| DNA Primers | 1 | 2018 | 1170 | 0.13 | Why? |
| Medical Informatics | 1 | 2021 | 648 | 0.13 | Why? |
| Cysteine Proteases | 1 | 2013 | 84 | 0.13 | Why? |
| Sputum | 1 | 2021 | 1720 | 0.12 | Why? |
| Ovarian Neoplasms | 1 | 2017 | 465 | 0.12 | Why? |
| Africa | 1 | 2021 | 2986 | 0.11 | Why? |
| Disease Eradication | 1 | 2018 | 581 | 0.11 | Why? |
| Mycobacterium tuberculosis | 1 | 2021 | 1164 | 0.11 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Depressive Disorder, Major | 1 | 2019 | 852 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2019 | 2149 | 0.09 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.09 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| Dog Diseases | 1 | 2013 | 745 | 0.08 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.07 | Why? |
| Neglected Diseases | 2 | 2021 | 381 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.07 | Why? |
| Tuberculosis | 1 | 2021 | 2895 | 0.07 | Why? |
| Europe | 1 | 2021 | 12702 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| HIV-1 | 1 | 2019 | 3365 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.06 | Why? |
| Humans | 20 | 2021 | 930598 | 0.06 | Why? |
| Mecamylamine | 1 | 2019 | 1 | 0.05 | Why? |
| Rhode Island | 1 | 2021 | 425 | 0.05 | Why? |
| Nicotinic Antagonists | 1 | 2019 | 6 | 0.05 | Why? |
| Dopamine Antagonists | 1 | 2019 | 13 | 0.05 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.05 | Why? |
| Benzazepines | 1 | 2019 | 49 | 0.05 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2013 | 3388 | 0.05 | Why? |
| Allelic Imbalance | 1 | 2017 | 2 | 0.05 | Why? |
| Amelogenin | 1 | 2017 | 2 | 0.05 | Why? |
| Medically Underserved Area | 1 | 2021 | 273 | 0.05 | Why? |
| Chromosomes, Human, Y | 1 | 2017 | 24 | 0.05 | Why? |
| Hydatidiform Mole | 1 | 2017 | 18 | 0.05 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Chromosomes, Human, X | 1 | 2017 | 81 | 0.04 | Why? |
| Microsatellite Repeats | 1 | 2017 | 99 | 0.04 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Animals | 4 | 2019 | 78931 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
| Confidentiality | 1 | 2021 | 581 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2019 | 987 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.04 | Why? |
| Global Burden of Disease | 1 | 2019 | 531 | 0.04 | Why? |
| Privacy | 1 | 2021 | 636 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.04 | Why? |
| Psychology | 1 | 2019 | 447 | 0.03 | Why? |
| Research Design | 2 | 2021 | 5830 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| User-Computer Interface | 1 | 2021 | 1068 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Life Expectancy | 1 | 2019 | 474 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2021 | 1216 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| HIV Antibodies | 1 | 2019 | 776 | 0.03 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 393 | 0.03 | Why? |
| Male | 7 | 2021 | 367725 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Female | 7 | 2021 | 380317 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2021 | 2259 | 0.03 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.03 | Why? |
| Policy | 1 | 2018 | 1372 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 436 | 0.03 | Why? |
| Microscopy | 1 | 2013 | 414 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2019 | 3776 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Dogs | 1 | 2013 | 2529 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Serologic Tests | 1 | 2019 | 4359 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.02 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| India | 1 | 2018 | 11875 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2013 | 6740 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Time Factors | 1 | 2013 | 31397 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.01 | Why? |
Adams's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(270)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_